Vivos Inc. announced that they filed a provisional patent application on the system equipment to support precision radionuclide therapy. This includes the shipping containers, the shielded vial holder, the Peltier chiller, and the syringe shields. These device designs are integrated into production standardization effort.

They can be used for treating a range of tumor sizes from 0.5-gram human lymph nodes to half-pound equine tumors. This equipment was just tested at recent equine therapy in NY. Eliminated the can and the lead pig containers and designed the shielding of the new plastic container to improve the ease of unpackaging and to ensure that can ship to White 1 label (UN2910) standards to reduce the Fed Ex shipping costs and logistics.

Incorporated stability in securing the vials while filing the syringes and maximized the vial holder wall thickness to further reduce the relatively low radiation. Designed to chill the vial holders and the syringes with a plug-in system. Avoids the potential contamination from ice baths, which was a Mayo Clinic concern for human clinical trials.

Contains an imbedded magnetic stirrer to keep the IsoPet solution particles in suspension. Each syringe port can be dedicated to a specific human lymph node, a specific VX-2 tumor in the animal testing, or as a staging center for treating larger animal tumors. Maximized the diameter of the syringe shield to reduce radiation while designing the finger position to maintain the optimum ergonomics.

Received very positive feedback from the therapists about the ergonomics. This flexibility is important to ensure the accuracy in precision injections.